Tumor Destructive Mechanical Impulse (TMI) Treatment of Solid Tumors. Part III: Transcranial Application, Immune Profile, Blood-Brain Barrier, Neuroprotection, Neuromodulation and Neurostimulation
Cellular Physiology and Biochemistry · 10.04.2026 · 60 (2) · 175-188
DOI: 10.33594/000000859 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cellular Physiology and Biochemistry, online erschienen am 10.04.2026. Verfasst von Axel Erich Theuer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venerology and Allergology, Charité University Hospital, Berlin, Germany. Hauptthemen laut MEDLINE: Brain Neoplasms, Melanoma. Gefördert von: Arbeitsgemeinschaft industrieller Forschungsvereinigungen (AiF), Zentrales Innovationsprogramm Mittelstand.
Abstract (Originalsprache)
Background/Aims: We explored the fundamental feasibility, technical frame conditions and effectiveness of transcranial Tumor Destructive Mechanical Impulse (TMI) treatment of brain tumors.
Methods
The optimal treatment parameters (total energy required, energy flux density, shock wave frequency) and applicator positions were explored and defined with respect to the special conditions given by propagation of shock waves through the skull.
Results
As first clinical observations, we present the outcome of transcranial TMI treatment in two cases with brain metastases of malignant melanoma. In both cases, regression of metastases as well in the brain as in other sites was observed, in one of the cases with a complete tumor free recovery.
Conclusion
In these cases, there were no identifiable signs of impairment of the surrounding brain tissue, and even indications of neuro-regenerative effects as described in the cited experimental literature, so that transcranial TMI treatment of brain tumors may be applied for further systematic investigation without any currently discernible risk for the intact surrounding brain tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Venerology and Allergology, Charité University Hospital, Berlin, Germany.
- Pediatrician's Office, Marktoberdorf, Germany.
- Department of Dermatology, University of Tübingen, Germany.
- EDOEAP (Unified Journalistic Organization of Supplementary Insurance and Health), Athens, Greece.
- Institute of Immunology, University of Duisburg-Essen, Essen, Germany.
- Shepherd Center Wound Clinic, Piedmont Atlanta Hospital, Atlanta, GA, USA.
Förderung
- Arbeitsgemeinschaft industrieller Forschungsvereinigungen (AiF)
- Zentrales Innovationsprogramm Mittelstand
Zitieren
APA
Theuer, A. E., Exner, S., Thomas, I., Lang, F., Mullins, J. D., Warlick, J., Strassmann, G., Eigentler, T. K., & Walter, G. F. (2026). Tumor Destructive Mechanical Impulse (TMI) Treatment of Solid Tumors. Part III: Transcranial Application, Immune Profile, Blood-Brain Barrier, Neuroprotection, Neuromodulation and Neurostimulation. Cellular Physiology and Biochemistry, 60(2), 175-188. https://doi.org/10.33594/000000859
Vancouver
Theuer AE, Exner S, Thomas I, Lang F, Mullins JD, Warlick J, et al. Tumor Destructive Mechanical Impulse (TMI) Treatment of Solid Tumors. Part III: Transcranial Application, Immune Profile, Blood-Brain Barrier, Neuroprotection, Neuromodulation and Neurostimulation. Cellular Physiology and Biochemistry. 2026;60(2):175-188. doi:10.33594/000000859
BibTeX
@article{Theuer2026,
author = {Theuer, Axel Erich and Exner, Stella and Thomas, Ioannis and Lang, Florian and Mullins, John David and Warlick, John and Strassmann, Gerd and Eigentler, Thomas K and Walter, Gerhard Franz},
title = {Tumor Destructive Mechanical Impulse (TMI) Treatment of Solid Tumors. Part III: Transcranial Application, Immune Profile, Blood-Brain Barrier, Neuroprotection, Neuromodulation and Neurostimulation},
journal = {Cellular Physiology and Biochemistry},
year = {2026},
volume = {60},
number = {2},
pages = {175--188},
doi = {10.33594/000000859}
}
EUVIMED